JP2014530010A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530010A5 JP2014530010A5 JP2014533316A JP2014533316A JP2014530010A5 JP 2014530010 A5 JP2014530010 A5 JP 2014530010A5 JP 2014533316 A JP2014533316 A JP 2014533316A JP 2014533316 A JP2014533316 A JP 2014533316A JP 2014530010 A5 JP2014530010 A5 JP 2014530010A5
- Authority
- JP
- Japan
- Prior art keywords
- rsv
- protein
- arginine
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000725643 Respiratory syncytial virus Species 0.000 claims 26
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims 17
- 239000004475 Arginine Substances 0.000 claims 7
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 7
- 150000001413 amino acids Chemical class 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 102000004961 Furin Human genes 0.000 claims 4
- 108090001126 Furin Proteins 0.000 claims 4
- 238000003776 cleavage reaction Methods 0.000 claims 4
- 230000007017 scission Effects 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 3
- 230000004927 fusion Effects 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 230000010076 replication Effects 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 108091006027 G proteins Proteins 0.000 claims 1
- 102000030782 GTP binding Human genes 0.000 claims 1
- 108091000058 GTP-Binding Proteins 0.000 claims 1
- 101710085938 Matrix protein Proteins 0.000 claims 1
- 101710127721 Membrane protein Proteins 0.000 claims 1
- 101710141454 Nucleoprotein Proteins 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161542040P | 2011-09-30 | 2011-09-30 | |
| US61/542,040 | 2011-09-30 | ||
| US201161542721P | 2011-10-03 | 2011-10-03 | |
| US61/542,721 | 2011-10-03 | ||
| US201261611834P | 2012-03-16 | 2012-03-16 | |
| US61/611,834 | 2012-03-16 | ||
| US201261614286P | 2012-03-22 | 2012-03-22 | |
| US61/614,286 | 2012-03-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014530010A JP2014530010A (ja) | 2014-11-17 |
| JP2014530010A5 true JP2014530010A5 (enExample) | 2016-09-29 |
Family
ID=47996397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014533316A Pending JP2014530010A (ja) | 2011-09-30 | 2012-09-27 | 呼吸器合胞体ウイルス用の組み換えナノ粒子ｒｓｖｆワクチン |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20130122032A1 (enExample) |
| EP (1) | EP2760469A4 (enExample) |
| JP (1) | JP2014530010A (enExample) |
| KR (1) | KR20140077169A (enExample) |
| CN (2) | CN104080476A (enExample) |
| AU (1) | AU2013201495B2 (enExample) |
| BR (1) | BR112014007616A2 (enExample) |
| CA (1) | CA2849471A1 (enExample) |
| HK (1) | HK1222125A1 (enExample) |
| IL (1) | IL231637A0 (enExample) |
| MX (1) | MX2014003777A (enExample) |
| RU (1) | RU2014117068A (enExample) |
| SG (2) | SG11201400999VA (enExample) |
| WO (1) | WO2013049342A1 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2370099T3 (en) | 2008-12-09 | 2016-08-01 | Novavax Inc | Rsv f modified proteins and methods of their use |
| US11446374B2 (en) | 2008-12-09 | 2022-09-20 | Novavax, Inc. | Modified RSV F proteins and methods of their use |
| BR112015025392A2 (pt) * | 2013-04-08 | 2017-10-10 | Medimmune Llc | composição de vacina e método de utilização |
| EP3049107A1 (en) * | 2013-09-24 | 2016-08-03 | Massachusetts Institute of Technology | Self-assembled nanoparticle vaccines |
| CN105087643A (zh) * | 2014-04-16 | 2015-11-25 | 中国科学院上海巴斯德研究所 | 重组表达人呼吸道合胞病毒f1蛋白胞外区的方法及表达系统 |
| WO2015195961A1 (en) * | 2014-06-18 | 2015-12-23 | Georgia State University And Research Foundation, Inc. | Recombinant rsv reporter virus |
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| CA2996762A1 (en) * | 2015-08-31 | 2017-03-09 | Technovax, Inc. | Human respiratory syncytial virus (hrsv) virus-like particles (vlps) based vaccine |
| JP6975709B2 (ja) * | 2015-09-02 | 2021-12-01 | ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. | 安定化したウイルスクラスｉ融合タンパク質 |
| CN114617959A (zh) | 2015-09-03 | 2022-06-14 | 诺瓦瓦克斯股份有限公司 | 具有改进的稳定性和免疫原性的疫苗组合物 |
| CN106547635B (zh) | 2015-09-18 | 2020-10-09 | 阿里巴巴集团控股有限公司 | 一种作业的操作重试方法和装置 |
| PE20181354A1 (es) | 2015-12-23 | 2018-08-22 | Pfizer | Mutantes de proteina f de rsv |
| KR20220041966A (ko) * | 2016-04-05 | 2022-04-01 | 얀센 백신스 앤드 프리벤션 비.브이. | 안정화된 용해성 융합-전 rsv f 단백질 |
| CN106124767A (zh) * | 2016-05-12 | 2016-11-16 | 广州瑞辉生物科技股份有限公司 | 呼吸道合胞病毒IgA抗体检测试纸条及其检测方法 |
| WO2018067300A1 (en) | 2016-10-03 | 2018-04-12 | University Of Massachusetts | Methods for immunizing pre-immune subjects against respiratory syncytial virus (rsv) |
| EP3595709A4 (en) * | 2017-03-15 | 2020-12-23 | Novavax, Inc. | METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES TO CLOSTRIDIUM DIFFICILE |
| JP7168938B2 (ja) | 2017-04-04 | 2022-11-10 | ユニヴァーシティ オブ ワシントン | パラミクソウイルスおよび／またはニューモウイルスのｆタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用 |
| CN107050446B (zh) * | 2017-04-19 | 2020-08-11 | 武汉博沃生物科技有限公司 | 经修饰的季节流感-rsv联合疫苗及其制备方法 |
| WO2019023196A1 (en) | 2017-07-24 | 2019-01-31 | Novavax, Inc. | METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE |
| WO2019063844A1 (en) * | 2017-09-29 | 2019-04-04 | Universiteit Antwerpen | VACCINATION AGAINST SYNCYTIAL RESPIRATORY VIRUS |
| CA3095216A1 (en) | 2018-02-28 | 2019-09-06 | University Of Washington | Self-asssembling nanostructure vaccines |
| US11278612B2 (en) | 2018-03-19 | 2022-03-22 | Novavax, Inc. | Multivalent influenza nanoparticle vaccines |
| KR102567994B1 (ko) * | 2018-10-12 | 2023-08-17 | 에스케이바이오사이언스(주) | 재조합 rsv 생백신주 및 이의 제조 방법 |
| WO2020092365A1 (en) * | 2018-10-29 | 2020-05-07 | Binh Ha | Rsv virus-like particles and methods of use thereof |
| KR102725189B1 (ko) * | 2018-11-01 | 2024-10-31 | 에스케이바이오사이언스(주) | 재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물 |
| CN113543803B (zh) * | 2019-02-28 | 2024-10-29 | Km生物医药股份公司 | Rsv f/g嵌合疫苗 |
| CN110229219B (zh) * | 2019-06-21 | 2021-03-30 | 中国科学院武汉病毒研究所 | 一种新型的呼吸道合胞病毒疫苗抗原的制备方法及其用途 |
| EP4097123A4 (en) * | 2020-01-27 | 2024-02-14 | Novavax, Inc. | CORONAVIRUS VACCINE FORMULATIONS |
| US10953089B1 (en) | 2020-01-27 | 2021-03-23 | Novavax, Inc. | Coronavirus vaccine formulations |
| WO2021198413A1 (en) * | 2020-04-02 | 2021-10-07 | Janssen Vaccines & Prevention B.V. | Stabilized vaccine compositions |
| CN113855796B (zh) * | 2021-07-30 | 2024-01-26 | 河北医科大学 | 卡介苗作为呼吸道合胞病毒灭活疫苗佐剂的应用 |
| TW202330922A (zh) * | 2021-11-19 | 2023-08-01 | 美商Ｒｎａ免疫公司 | 核糖核酸呼吸道融合病毒(rsv)疫苗之組合物及方法 |
| KR102785012B1 (ko) * | 2021-12-14 | 2025-03-20 | 경희대학교 산학협력단 | Rsv 항원 단백질을 포함하는 바이러스 유사입자 및 이를 이용한 백신 |
| TW202417469A (zh) * | 2022-09-01 | 2024-05-01 | 美商諾瓦瓦克斯股份有限公司 | 純化供用於疫苗組成物之具有疏水性膜結構域的病毒蛋白的下游程序 |
| CN117986382B (zh) * | 2022-11-04 | 2025-04-01 | 北京康乐卫士生物技术股份有限公司 | 针对rsv的重组亚单位疫苗及其应用 |
| WO2024259624A1 (en) * | 2023-06-21 | 2024-12-26 | Shenzhen Genius Biotech Service Co. Ltd | A modified rsv f protein, a nanoparticle, a composition and a vaccine against respiratory syncytial virus infection |
| WO2024260446A1 (zh) * | 2023-06-21 | 2024-12-26 | 深圳深信生物科技有限公司 | 呼吸道合胞病毒(rsv)疫苗 |
| WO2025026448A1 (zh) * | 2023-08-03 | 2025-02-06 | 广州穗和生物技术有限公司 | 修饰的呼吸道合胞病毒f蛋白及其用途 |
| CN119569835A (zh) * | 2023-09-07 | 2025-03-07 | 北京科兴中维生物技术有限公司 | 呼吸道合胞病毒f蛋白及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006524511A (ja) * | 2003-04-25 | 2006-11-02 | メッドイミューン バクシーンズ，インコーポレイティド | メタニューモウイルス由来の異種抗原を含む組換えパラインフルエンザウイルス発現系およびワクチン |
| EP2181121A4 (en) * | 2007-03-21 | 2012-07-11 | Id Biomedical Corp Quebec | CHIMÄRE ANTIGENE |
| CN101801411A (zh) * | 2007-07-19 | 2010-08-11 | 诺瓦瓦克斯股份有限公司 | 嵌合水痘带状疱疹病毒病毒样颗粒 |
| SI2222710T1 (sl) * | 2007-12-24 | 2016-11-30 | Id Biomedical Corporation Of Quebec | Rekombinatni RSV antigeni |
| EP2254554A1 (en) * | 2008-02-25 | 2010-12-01 | Novavax, Inc. | Sugar glassified virus like particles (vlps) |
| KR101027159B1 (ko) * | 2008-07-28 | 2011-04-05 | 뮤추얼아이피서비스(주) | 타겟 영상 검출 장치 및 그 방법 |
| DK2370099T3 (en) * | 2008-12-09 | 2016-08-01 | Novavax Inc | Rsv f modified proteins and methods of their use |
| WO2010077712A1 (en) * | 2008-12-09 | 2010-07-08 | Novavax, Inc. | Bovine respiratory syncytial virus virus-like particle (vlps) |
-
2012
- 2012-09-27 AU AU2013201495A patent/AU2013201495B2/en not_active Ceased
- 2012-09-27 US US13/629,107 patent/US20130122032A1/en not_active Abandoned
- 2012-09-27 JP JP2014533316A patent/JP2014530010A/ja active Pending
- 2012-09-27 CN CN201280059282.1A patent/CN104080476A/zh active Pending
- 2012-09-27 SG SG11201400999VA patent/SG11201400999VA/en unknown
- 2012-09-27 EP EP12835033.7A patent/EP2760469A4/en not_active Withdrawn
- 2012-09-27 CA CA2849471A patent/CA2849471A1/en not_active Abandoned
- 2012-09-27 SG SG10201602434UA patent/SG10201602434UA/en unknown
- 2012-09-27 MX MX2014003777A patent/MX2014003777A/es unknown
- 2012-09-27 WO PCT/US2012/057546 patent/WO2013049342A1/en not_active Ceased
- 2012-09-27 RU RU2014117068/10A patent/RU2014117068A/ru not_active Application Discontinuation
- 2012-09-27 BR BR112014007616A patent/BR112014007616A2/pt active Search and Examination
- 2012-09-27 CN CN201510769961.3A patent/CN105381457A/zh active Pending
- 2012-09-27 KR KR1020147009538A patent/KR20140077169A/ko not_active Withdrawn
-
2014
- 2014-03-20 IL IL231637A patent/IL231637A0/en unknown
-
2015
- 2015-02-27 US US14/634,162 patent/US20150335730A1/en not_active Abandoned
- 2015-02-27 US US14/634,171 patent/US20150306207A1/en not_active Abandoned
-
2016
- 2016-08-31 HK HK16110329.3A patent/HK1222125A1/zh unknown
-
2017
- 2017-02-15 US US15/433,759 patent/US20170319682A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530010A5 (enExample) | ||
| RU2014117068A (ru) | Вакцина на основе рекомбинантных наночастиц f из rsv против респираторно-синцитиального вируса | |
| JP6957580B2 (ja) | 新規多価ナノ粒子に基づくワクチン | |
| Hemann et al. | Protective CD8 T cell–mediated immunity against influenza a virus infection following influenza virus–like particle vaccination | |
| Boyoglu-Barnum et al. | Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice | |
| Haynes | Progress and challenges in RSV prophylaxis and vaccine development | |
| RU2015138530A (ru) | Комбинированная вакцина против респираторно-синцитиального вируса и вируса гриппа | |
| Elkashif et al. | Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections | |
| Volpatti et al. | Polymersomes decorated with the SARS-CoV-2 spike protein receptor-binding domain elicit robust humoral and cellular immunity | |
| JP2015509707A5 (enExample) | ||
| JP2022533318A (ja) | 気道感染の治療または予防のためのサブユニットワクチン | |
| RU2011128371A (ru) | Модифицированные f протеины sv и способы их применения | |
| JP2014502156A5 (enExample) | ||
| JP2012501959A5 (enExample) | ||
| JP2015536134A5 (enExample) | ||
| HRP20240996T1 (hr) | Prefuzija rsv f proteina i njihova uporaba | |
| JP2016510983A5 (enExample) | ||
| JP2015517489A5 (enExample) | ||
| JP2015524422A5 (enExample) | ||
| BR112014015390A2 (pt) | vírus da estomatite vesicular para vacinas iniciais e de reforço | |
| JP2015506705A5 (enExample) | ||
| Kotomina et al. | Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease | |
| JP2013518052A5 (enExample) | ||
| JP2015500827A5 (enExample) | ||
| JP2016504993A5 (enExample) |